FDA.reportPublic FDA data

Multiple blood-borne pathogen antibody/antigen IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of antibodies to, and antigens from multiple blood-borne pathogens in a clinical specimen. Pathogens detected may include (but are not limited to) human immunodeficiency virus 1 and 2 (HIV1 and HIV2), Hepatitis B virus, Hepatitis C virus, human T-cell lymphotrophic virus 1 and/or 2 (HTLV1 and/or HTLV2), and Treponema pallidum.
GUDID devices
4
Last updated
2020-05-20 06:02:04

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
05055273216493SEROLOGY NEGATIVE CONTROL (SEROLOGY CONTROL -)RANDOX LABORATORIES LIMITEDSR103512020-05-11
05055273216509SEROLOGY I POSITIVE CONTROL (SEROLOGY I CONTROL +)RANDOX LABORATORIES LIMITEDSR103522020-05-11
05055273216516SEROLOGY II POSITIVE CONTROL (SEROLOGY II CONTROL +)RANDOX LABORATORIES LIMITEDSR103532020-05-11
05055273216523SEROLOGY III POSITIVE CONTROL (SEROLOGY III CONTROL +)RANDOX LABORATORIES LIMITEDSR103542020-05-11